A conversation with Gerhard Bothma (Part 2)

We spoke with Gerhard Bothma, Senior Manager, HEMAR and Tender Management,…


Accelerated Access Review in the UK: Understanding the Priorities of the NHS

This is the second post of the Conditional Reimbursement Series focusing on…


A conversation with Gerhard Bothma (Part 1)

We spoke with Gerhard Bothma, Senior Manager, HEMAR and Tender Management,…


Conditional Reimbursement: A Fast Track?

It is not news that the medical technology industry is one of the most…


A conversation with Jeff Stonadge

We spoke with Jeff Stonadge, Director of Strategic Reimbursement, to discuss…


A Business Model for Wearable Medical Technologies

To create innovative, medical technology, companies have to look at what…


How Not to Reduce your Reimbursement

“The VALUE of medical technologies is determined by the market…


A conversation with Tania Sherry of Medtronic

We spoke with Tania Sherry, European Market Development Manager (PillCam Colon…


A conversation with Amit Kukreja of Second Sight

We sat down with Amit Kukreja, Director of Market Access, Reimbursement &…


The Value of Surgical Robotics: Can We Afford It?

In 1985, a group of neurosurgeons placed a biopsy needle in the brain of a…